Recursion Pharmaceuticals, Inc. (RXRX) — SC 13G/A Filings
All SC 13G/A filings from Recursion Pharmaceuticals, Inc.. Browse 11 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (11)
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 8, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 22, 2024
- SC 13G/A Filing — Oct 18, 2024
- SC 13G/A Filing — Feb 13, 2024
-
ARK Investment Management Updates Recursion Pharma Stake
— Feb 12, 2024 Risk: low
ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on February 12, 2024, disclosing its ownership in Recursion Pharmaceuticals, Inc. A -
BlackRock Amends Recursion Pharma Stake, Signals Continued Confidence
— Jan 29, 2024
BlackRock Inc. filed an amended SC 13G/A on January 29, 2024, indicating its ownership of Class A Common Stock in Recursion Pharmaceuticals, Inc. as of December -
Baillie Gifford Amends Recursion Pharma Stake (SC 13G/A)
— Jan 26, 2024
Baillie Gifford & Co, a major investment management firm, filed an amendment (SC 13G/A) on January 26, 2024, indicating a change in their ownership of Recursion
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX